Active substance
Chlorpromazine
- SFDA 3
- US FDA 88
- Health Canada 3
- US price lines 5
- NHS prices 7
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Promazi | 100 mg | Tablet · Oral use | 30 Blister | SAR 291.00 | Generic · Prescription | Saudi Amarox | Valid |
| Promazi | 25 mg | Tablet · Oral use | 30 Blister | SAR 72.75 | Generic · Prescription | Saudi Amarox | Valid |
| Promazi | 25 mg/ml | Solution for injection · Intramuscular use | 1 Vial | SAR 41.05 | Generic · Prescription | Saudi Amarox | Valid |
Indications — CHI Daman Drug Formulary
SCHIZOPHRENIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | DR REDDYS | Prescription | 13 Feb 1974 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG | tablet · oral | UPSHER SMITH LABS | Prescription | 9 Jul 1974 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG | tablet · oral | UPSHER SMITH LABS | Prescription | 9 Jul 1974 |
| CHLORPROMAZINE HYDROCHLORIDE | 50MG | tablet · oral | UPSHER SMITH LABS | Prescription | 9 Jul 1974 |
| CHLORPROMAZINE HYDROCHLORIDE | 100MG | tablet · oral | UPSHER SMITH LABS | Prescription | 9 Jul 1974 |
| CHLORPROMAZINE HYDROCHLORIDE | 200MG | tablet · oral | UPSHER SMITH LABS | Prescription | 9 Jul 1974 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 25 Jul 1974 |
| SONAZINE | 30MG/ML; 100MG/ML | concentrate · oral | SCIEGEN PHARMS | Prescription | 1 Mar 1976 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | AMNEAL PHARMS CO | Prescription | 10 Sep 2018 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | ZYDUS LIFESCIENCES | Prescription | 17 Jan 2020 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | EUGIA PHARMA | Prescription | 7 Jul 2020 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | SOMERSET THERAPS LLC | Prescription | 31 Aug 2020 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | LANNETT CO INC | Prescription | 22 Jan 2021 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | GLENMARK PHARMS LTD | Prescription | 23 Mar 2021 |
| CHLORPROMAZINE HYDROCHLORIDE | 30MG/ML; 100MG/ML | concentrate · oral | GENUS | Prescription | 2 Jun 2021 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | TEVA PHARMS | Prescription | 25 Oct 2021 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | CHARTWELL RX | Prescription | 29 Nov 2021 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG; 50MG; 100MG; 200MG | tablet · oral | MSN | Prescription | 27 Jan 2022 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | LUPIN | Prescription | 13 Jul 2023 |
| CHLORPROMAZINE HYDROCHLORIDE | 10MG; 25MG; 50MG; 100MG; 200MG | tablet · oral | ALEMBIC | Prescription | 18 Jul 2023 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | ZYDUS PHARMS | Prescription | 13 Mar 2024 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | REGCON HOLDINGS | Prescription | 24 Sep 2024 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | GLAND | Prescription | 4 Oct 2024 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | ASPIRO | Prescription | 18 Nov 2024 |
| CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | injectable · injection | THINQ PHARM-CRO PVT | Prescription | 10 Dec 2024 |
63 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| TEVA-CHLORPROMAZINE | 00232807 | 50.0 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-CHLORPROMAZINE | 00232823 | 25.0 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TEVA-CHLORPROMAZINE | 00232831 | 100 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CHLORPROMAZINE 10 MG TABLET | $0.24183 | per EA | 23 Sep 2026 |
| US NADAC | CHLORPROMAZINE 100 MG TABLET | $0.55242 | per EA | 23 Sep 2026 |
| US NADAC | CHLORPROMAZINE 200 MG TABLET | $0.66357 | per EA | 23 Sep 2026 |
| US NADAC | CHLORPROMAZINE 25 MG TABLET | $0.32443 | per EA | 23 Sep 2026 |
| US NADAC | CHLORPROMAZINE 50 MG TABLET | $0.41446 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Chlorpromazine 100mg tablets | £43.98 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Chlorpromazine 100mg/5ml oral solution | £35.68 | 150 ml | 1 Oct 2026 |
| NHS Drug Tariff | Chlorpromazine 10mg tablets | £54.05 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Chlorpromazine 25mg tablets | £31.13 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Chlorpromazine 25mg/5ml oral solution | £6.00 | 150 ml | 1 Oct 2026 |
| NHS Drug Tariff | Chlorpromazine 25mg/5ml oral solution sugar free | £12.30 | 150 ml | 1 Oct 2026 |
| NHS Drug Tariff | Chlorpromazine 50mg tablets | £30.11 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 24.1. Medicines for psychotic disorders · core (EML); complementary (EMLc)
Therapeutic equivalent to haloperidol for Schizophrenia or other primary psychotic disorders
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.